Michael Erman on Muck Rack

Michael Erman

Verified
United States
As seen in: Reuters, Folha de S.Paulo, G1 Globo, MSN, MSN Brasil, MSN Ireland, MSN Singapore, O Globo, UOL, Yahoo Entertainment, Yahoo Life and
I write for Reuters. My articles can be found here: www.reuters.com/journalists/michael-erman
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bristol Myers drug delays myeloma progression in hard to treat patients

|
By Michael Erman 
| The Charlotte Observer
FILE PHOTO: Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Bristol Myers Squibb said on Friday that its experimental oral drug mezigdomide delayed disease progression in a late-stage trial of multiple myeloma patients whose illness had relapsed or not responded to other treatments.
Open in Who Shared View Duplicates (74) Issue with article?
See all 17,433 licensed articles (17,572 Total)

Actions

Share this page

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified